712 North excited to be funded by the National Institute of Health

712 North CEO Marcel V. Alavi spoke with Proactive at the Bio Investor Forum in San Francisco.
Privately-held 712 North is an early-stage biotech developing personalized mitochondrial medicines for patients with Alzheimer’s and other age-related diseases.

Post Author: hatefull